Drug that targets an inflammatory enzyme could help prevent lung cancer
A new study by MIT researchers shows that inhibiting caspase-1 can reduce the risk of tumor growth.
A new study by MIT researchers shows that inhibiting caspase-1 can reduce the risk of tumor growth.
A new short film from MIT Open Learning explores the influential career of Institute Professor and School of Engineering Dean Paula Hammond.
Derived from patient tumor samples and available to researchers around the world, the cells will aid the development of new cancer treatments.
Study finds non-experts deferred to LLM-based diagnostic assistance, even when it was wrong, while clinicians caught AI errors.
The visionary PhysioNet platform launched 25 years ago, based on a system developed at MIT in the 1970s. It has become one of the most comprehensive biomedical and clinical data repositories in existence.
The PhD candidate builds soft bioelectronic technologies to decode signals between the brain and the rest of the body.
Researchers developed an optical nanosensor to rapidly detect a key gut biomarker, enabling faster, accessible screening.
After being swallowed, the devices could offer continuous monitoring of patients who are sick or at risk of hypothermia.
Their new gel-like drug formulation can coat the esophageal lining and release drugs that could help treat inflammatory conditions affecting the esophagus.
Thomas Levenson’s new book shows how arguments against vaccination reach back to the beginning of the technology itself.
MIT researchers have designed an ultrasound system that creates a real-time 3D representation of the object being imaged.
The adjuvant can help the injectable polio vaccine induce a strong immune response in the GI tract, which is considered critical to eradicating the virus.
The MIT Marble Center for Cancer Nanomedicine looks back at 10 years of turning big ideas about nanotechnology into transformative advances for cancer patients.
The professor of medical engineering and science is honored for medical research that has led to better treatments for cardiovascular disease.
Using immune-remodeling mRNA molecules, researchers generated T cells that can slow tumor growth and, in some cases, eradicate tumors.